All publications
How common is the mutation E138K in the UK? 18th Annual Conference of the British HIV Association, 18-20 April 2012.
.
2012. Persistence of transmitted HIV drug resistance mutations. International Workshop on HIV & Hepatitis Virus Resistance and Curative Strategies, 5-9 June 2012. Antiviral Therapy 17 Suppl 1:A167.
.
2012. Phylogenetic analysis of HIV transmission among different ethnic MSM groups in the UK. 19th Conference on Retroviruses and Opportunistic Infections, 5-8 March 2012.
.
2012. Population based study indicates viral genetic effect on HIV virulence is small but significant. 19th Conference on Retroviruses and Opportunistic Infections, 5-8 March 2012.
.
2012. The prevalence of darunavir-associated mutations in HIV-1-infected children in the UK. Antivir Ther. 17:599-603.
.
2012. Significant HIV-1 subtype differences observed in the development of accessory mutations associated with high-level resistance to reverse transcriptase inhibitors. International Workshop on HIV & Hepatitis Virus Resistance and Curative Strategies, 5-9 June 2012. Antiviral Therapy 17 Suppl 1:A84.
.
2012. Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study. BMJ. 345:e5253.
.
2012. Transmission dynamics of CRF50_A1D across most at risk communities in the UK. 19th International HIV Dynamics & Evolution Conference, 25-28 April 2012.
.
2012. Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-score PLoS One. 6:e25665.
.
2011. The contribution of recent infections to HIV-1 transmission clusters in the UK. 18th International HIV Dynamics and Evolution Conference, 1-4 May 2011.
.
2011. Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study. J Antimicrob Chemother. 66:1886-96.
.
2011. Different drug-resistance development in HIV-1 infected patients failing a first-line antiretroviral therapy containing NNRTIs. IAS, 17-20 July 2011.
.
2011. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis. 11:363-71.
.
2011. Genotypic resistance testing in routine clinical care. Curr Opin HIV AIDS. 6:251-7.
.
2011. HIV transmission dynamics. Keystone Conference on HIV Evolution, Genomics and Pathogenesis, 26-31March 2011.
.
2011. The impact of HIV drug resistance testing on changes to treatment. AIDS. 25:603-10.
.
2011. Impact of Viral Subtype on Immunologic and Clinical Disease Progression in Antiretroviral-naïve HIV-infected Adults. 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.
.
2011. Mapping the circulation of HIV-1 recombinants among MSM. 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.
.
2011. Phylogeographic and Risk Group Characteristics of HIV Subtype A Transmission in the UK. 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.
.
2011. Phylogeographic and risk group characteristics of HIV-1 Subtype A transmission in the UK. 18th International HIV Dynamics and Evolution Conference, 1-4 May 2011.
.
2011.